Dimethyl fumarate 120 mg

Dimethyl fumarate 240 mg

Sanfedra contains dimethyl fumarate that is indicated for the treatment of patients with relapsing forms of multiple sclerosis.

• FDA-approved as first-line treatment for relapsing forms of multiple sclerosis.
• Prevents disability from worsening and improves quality of life.
• Reduces risk of multiple sclerosis relapse.
• Has immunomodulatory and neuroprotective effects.
• Well-tolerated.